Shaukat A

References (2)

Title : FDA Approval of Donanemab-azbt: A New Dawn in Alzheimer's Disease Treatment - Riaz_2026_Health.Sci.Rep_9_e72688
Author(s) : Riaz R , Fatima M , Ramzan S , Rathi D , Fatima F , Farooq M , Shaukat A , Khaliq N , Akilimali A
Ref : Health Sci Rep , 9 :e72688 , 2026
Abstract :
PubMedSearch : Riaz_2026_Health.Sci.Rep_9_e72688
PubMedID: 42338648

Title : Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast alpha-glucosidase, acetylcholinesterase and butyrylcholinesterase - Riaz_2015_Bioorg.Chem_63_64
Author(s) : Riaz S , Khan IU , Bajda M , Ashraf M , Qurat Ul A , Shaukat A , Rehman TU , Mutahir S , Hussain S , Mustafa G , Yar M
Ref : Bioorg Chem , 63 :64 , 2015
Abstract :
PubMedSearch : Riaz_2015_Bioorg.Chem_63_64
PubMedID: 26451651